122 related articles for article (PubMed ID: 36690302)
21. Prognostic value of computed tomography texture features in non-small cell lung cancers treated with definitive concomitant chemoradiotherapy.
Ahn SY; Park CM; Park SJ; Kim HJ; Song C; Lee SM; McAdams HP; Goo JM
Invest Radiol; 2015 Oct; 50(10):719-25. PubMed ID: 26020832
[TBL] [Abstract][Full Text] [Related]
22. Survival results and prognostic factors in T4 N0-3 non-small cell lung cancer patients according to the AJCC 7th edition staging system.
Arslan D; Bozcuk H; Gunduz S; Tural D; Tattli AM; Uysal M; Goksu SS; Bassorgun Cİ; Koral L; Coskun HS; Ozdogan M; Savas B
Asian Pac J Cancer Prev; 2014; 15(6):2465-72. PubMed ID: 24761848
[TBL] [Abstract][Full Text] [Related]
23. Development and Validation of an Immune-Based Prognostic Risk Score for Patients With Resected Non-Small Cell Lung Cancer.
He L; Huang Y; Chen X; Huang X; Wang H; Zhang Y; Liang C; Li Z; Yan L; Liu Z
Front Immunol; 2022; 13():835630. PubMed ID: 35401554
[TBL] [Abstract][Full Text] [Related]
24. Prognostic Significance of Standardized Uptake Value of Lymph Nodes on Survival for Stage III Non-small Cell Lung Cancer Treated With Definitive Concurrent Chemoradiotherapy.
Lee VH; Chan WW; Lee EY; Choy TS; Ho PP; Leung DK; Lam KO; Kwong DL; Leung TW; Khong PL
Am J Clin Oncol; 2016 Aug; 39(4):355-62. PubMed ID: 24710123
[TBL] [Abstract][Full Text] [Related]
25. Prognostic value of metabolic tumor burden from (18)F-FDG PET in surgical patients with non-small-cell lung cancer.
Zhang H; Wroblewski K; Liao S; Kampalath R; Penney BC; Zhang Y; Pu Y
Acad Radiol; 2013 Jan; 20(1):32-40. PubMed ID: 22999369
[TBL] [Abstract][Full Text] [Related]
26. Pretreatment
Dissaux G; Visvikis D; Da-Ano R; Pradier O; Chajon E; Barillot I; Duvergé L; Masson I; Abgral R; Santiago Ribeiro MJ; Devillers A; Pallardy A; Fleury V; Mahé MA; De Crevoisier R; Hatt M; Schick U
J Nucl Med; 2020 Jun; 61(6):814-820. PubMed ID: 31732678
[TBL] [Abstract][Full Text] [Related]
27. Early response evaluation using primary tumor and nodal imaging features to predict progression-free survival of locally advanced non-small cell lung cancer.
Zhang N; Liang R; Gensheimer MF; Guo M; Zhu H; Yu J; Diehn M; Loo BW; Li R; Wu J
Theranostics; 2020; 10(25):11707-11718. PubMed ID: 33052242
[TBL] [Abstract][Full Text] [Related]
28. The Prognostic Role of PORT and EGFR Mutation Status in Completely Resected Stage IIIA/N2 Non-Small Cell Lung Cancer Patients with Postoperative Chemotherapy.
Yang H; Wang K; Li S; Li Y; Yuan L
Pathol Oncol Res; 2021; 27():1609898. PubMed ID: 34447289
[No Abstract] [Full Text] [Related]
29. Developing and Validating a Survival Prediction Model for NSCLC Patients Through Distributed Learning Across 3 Countries.
Jochems A; Deist TM; El Naqa I; Kessler M; Mayo C; Reeves J; Jolly S; Matuszak M; Ten Haken R; van Soest J; Oberije C; Faivre-Finn C; Price G; de Ruysscher D; Lambin P; Dekker A
Int J Radiat Oncol Biol Phys; 2017 Oct; 99(2):344-352. PubMed ID: 28871984
[TBL] [Abstract][Full Text] [Related]
30. Is pulmonary artery a dose-limiting organ at risk in non-small cell lung cancer patients treated with definitive radiotherapy?
Ma JT; Sun L; Sun X; Xiong ZC; Liu Y; Zhang SL; Huang LT; Han CB
Radiat Oncol; 2017 Feb; 12(1):34. PubMed ID: 28143532
[TBL] [Abstract][Full Text] [Related]
31. SUVmax Predicts Disease Progression after Stereotactic Ablative Radiotherapy in Stage I Non-small Cell Lung Cancer.
Kwak YK; Park HH; Choi KH; Park EY; Sung SY; Lee SW; Hong JH; Lee HC; Yoo IR; Kim YS
Cancer Res Treat; 2020 Jan; 52(1):85-97. PubMed ID: 31122008
[TBL] [Abstract][Full Text] [Related]
32. A novel deep learning prognostic system improves survival predictions for stage III non-small cell lung cancer.
Yang L; Fan X; Qin W; Xu Y; Zou B; Fan B; Wang S; Dong T; Wang L
Cancer Med; 2022 Nov; 11(22):4246-4255. PubMed ID: 35491970
[TBL] [Abstract][Full Text] [Related]
33. The impact of order with radiation therapy in stage IIIA pathologic N2 NSCLC patients: a population-based study.
Duan H; Liang L; Xie S; Wang C
BMC Cancer; 2020 Aug; 20(1):809. PubMed ID: 32847544
[TBL] [Abstract][Full Text] [Related]
34. Imaging features from pretreatment CT scans are associated with clinical outcomes in nonsmall-cell lung cancer patients treated with stereotactic body radiotherapy.
Li Q; Kim J; Balagurunathan Y; Liu Y; Latifi K; Stringfield O; Garcia A; Moros EG; Dilling TJ; Schabath MB; Ye Z; Gillies RJ
Med Phys; 2017 Aug; 44(8):4341-4349. PubMed ID: 28464316
[TBL] [Abstract][Full Text] [Related]
35. The prognostic impact of tumor volume on stage I non-small cell lung cancer.
Su XD; Xie HJ; Liu QW; Mo YX; Long H; Rong TH
Lung Cancer; 2017 Feb; 104():91-97. PubMed ID: 28213008
[TBL] [Abstract][Full Text] [Related]
36. Pre-treatment CT imaging in stage IIIA lung cancer: Can we predict local recurrence after definitive chemoradiotherapy?
Plodkowski AJ; Araujo-Filho JAB; Simmers CDA; Girshman J; Raj M; Zheng J; Rimner A; Ginsberg MS
Clin Imaging; 2021 Jan; 69():133-138. PubMed ID: 32721848
[TBL] [Abstract][Full Text] [Related]
37. Applicability of a prognostic CT-based radiomic signature model trained on stage I-III non-small cell lung cancer in stage IV non-small cell lung cancer.
de Jong EEC; van Elmpt W; Rizzo S; Colarieti A; Spitaleri G; Leijenaar RTH; Jochems A; Hendriks LEL; Troost EGC; Reymen B; Dingemans AC; Lambin P
Lung Cancer; 2018 Oct; 124():6-11. PubMed ID: 30268481
[TBL] [Abstract][Full Text] [Related]
38. Cone-beam CT radiomics features might improve the prediction of lung toxicity after SBRT in stage I NSCLC patients.
Qin Q; Shi A; Zhang R; Wen Q; Niu T; Chen J; Qiu Q; Wan Y; Sun X; Xing L
Thorac Cancer; 2020 Apr; 11(4):964-972. PubMed ID: 32061061
[TBL] [Abstract][Full Text] [Related]
39. Prediction and verification of survival in patients with non-small-cell lung cancer based on an integrated radiomics nomogram.
Li R; Peng H; Xue T; Li J; Ge Y; Wang G; Feng F
Clin Radiol; 2022 Mar; 77(3):e222-e230. PubMed ID: 34974912
[TBL] [Abstract][Full Text] [Related]
40. Validation of Independent Prognostic Value of Asphericity of
Rogasch JMM; Furth C; Chibolela C; Hofheinz F; Ochsenreither S; Rückert JC; Neudecker J; Böhmer D; von Laffert M; Amthauer H; Frost N
Clin Lung Cancer; 2020 May; 21(3):264-272.e6. PubMed ID: 31839531
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
